FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220681646> ?p ?o ?g. }

• W4220681646 endingPage "1078" @default.
• W4220681646 startingPage "1070" @default.
• W4220681646 abstract "Nafamostat mesylate (NM) is used clinically in combination with antiviral drugs to treat coronavirus disease (COVID-19). One of the adverse events of NM is hyperkalaemia due to inhibition of the amiloride-sensitive sodium channels (ENaC). The incidence and risk factors for hyperkalaemia due to NM have been studied in patients with pancreatitis but not in COVID-19. COVID-19 can be associated with hypokalaemia or hyperkalaemia, and SARS-CoV-2 is thought to inhibit ENaC. Therefore, frequency and risk factors for hyperkalaemia due to NM may differ between COVID-19 and pancreatitis. Hyperkalaemia may worsen the respiratory condition of patients. The objective of this study was to determine the incidence and risk factors for hyperkalaemia in COVID-19 patients treated with favipiravir, dexamethasone and NM.This retrospective study reviewed the records of hospitalized COVID-19 patients treated with favipiravir and dexamethasone, with or without NM, between March 2020 and January 2021. Multivariable logistic regression analysis was performed to identify the risk factors for hyperkalaemia.Of 45 patients who received favipiravir and dexamethasone with NM for the treatment of COVID-19, 21 (47%) experienced hyperkalaemia. The duration of NM administration was a significant predictor of hyperkalaemia (odds ratio: 1.55, 95% confidence interval: 1.04-2.31, p = 0.031). The receiver-operating characteristic curve analysis determined that the cut-off value for predicting the number of days until the onset of hyperkalaemia was 6 days and the area under the curve was 0.707.This study revealed that the incidence of hyperkalaemia is high in patients treated for COVID-19 with NM, and that the duration of NM administration is a key risk factor. When NM is administered for the treatment of COVID-19, it should be discontinued within 6 days to minimize the risk of hyperkalaemia." @default.
• W4220681646 created "2022-04-03" @default.
• W4220681646 creator A5012543365 @default.
• W4220681646 creator A5021528399 @default.
• W4220681646 creator A5022445606 @default.
• W4220681646 creator A5058991394 @default.
• W4220681646 creator A5061131089 @default.
• W4220681646 creator A5074602663 @default.
• W4220681646 creator A5079703667 @default.
• W4220681646 creator A5083455636 @default.
• W4220681646 date "2022-03-21" @default.
• W4220681646 modified "2023-09-26" @default.
• W4220681646 title "Incidence and risk factors for hyperkalaemia in patients treated for COVID‐19 with nafamostat mesylate" @default.
• W4220681646 cites W1229843715 @default.
• W4220681646 cites W1964422445 @default.
• W4220681646 cites W2022849282 @default.
• W4220681646 cites W2052333415 @default.
• W4220681646 cites W2059098016 @default.
• W4220681646 cites W2092214209 @default.
• W4220681646 cites W2096293984 @default.
• W4220681646 cites W2128791489 @default.
• W4220681646 cites W2141351444 @default.
• W4220681646 cites W2144261534 @default.
• W4220681646 cites W2146690541 @default.
• W4220681646 cites W2151696061 @default.
• W4220681646 cites W2433370208 @default.
• W4220681646 cites W3004318991 @default.
• W4220681646 cites W3006371943 @default.
• W4220681646 cites W3009912996 @default.
• W4220681646 cites W3012849736 @default.
• W4220681646 cites W3016535995 @default.
• W4220681646 cites W3017258575 @default.
• W4220681646 cites W3017302293 @default.
• W4220681646 cites W3027630905 @default.
• W4220681646 cites W3030602524 @default.
• W4220681646 cites W3031330053 @default.
• W4220681646 cites W3033543683 @default.
• W4220681646 cites W3033703522 @default.
• W4220681646 cites W3039031817 @default.
• W4220681646 cites W3047640609 @default.
• W4220681646 cites W3084620550 @default.
• W4220681646 cites W3090713315 @default.
• W4220681646 cites W3094171379 @default.
• W4220681646 cites W3095162843 @default.
• W4220681646 cites W3111034637 @default.
• W4220681646 cites W3119077632 @default.
• W4220681646 cites W3119726992 @default.
• W4220681646 cites W3163967588 @default.
• W4220681646 cites W4210642183 @default.
• W4220681646 cites W4220681646 @default.
• W4220681646 cites W4302405037 @default.
• W4220681646 doi "https://doi.org/10.1111/jcpt.13646" @default.
• W4220681646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35313385" @default.
• W4220681646 hasPublicationYear "2022" @default.
• W4220681646 type Work @default.
• W4220681646 citedByCount "3" @default.
• W4220681646 countsByYear W42206816462022 @default.
• W4220681646 countsByYear W42206816462023 @default.
• W4220681646 crossrefType "journal-article" @default.
• W4220681646 hasAuthorship W4220681646A5012543365 @default.
• W4220681646 hasAuthorship W4220681646A5021528399 @default.
• W4220681646 hasAuthorship W4220681646A5022445606 @default.
• W4220681646 hasAuthorship W4220681646A5058991394 @default.
• W4220681646 hasAuthorship W4220681646A5061131089 @default.
• W4220681646 hasAuthorship W4220681646A5074602663 @default.
• W4220681646 hasAuthorship W4220681646A5079703667 @default.
• W4220681646 hasAuthorship W4220681646A5083455636 @default.
• W4220681646 hasBestOaLocation W42206816461 @default.
• W4220681646 hasConcept C120665830 @default.
• W4220681646 hasConcept C121332964 @default.
• W4220681646 hasConcept C126322002 @default.
• W4220681646 hasConcept C156957248 @default.
• W4220681646 hasConcept C197934379 @default.
• W4220681646 hasConcept C42219234 @default.
• W4220681646 hasConcept C44249647 @default.
• W4220681646 hasConcept C61511704 @default.
• W4220681646 hasConcept C71924100 @default.
• W4220681646 hasConcept C90924648 @default.
• W4220681646 hasConceptScore W4220681646C120665830 @default.
• W4220681646 hasConceptScore W4220681646C121332964 @default.
• W4220681646 hasConceptScore W4220681646C126322002 @default.
• W4220681646 hasConceptScore W4220681646C156957248 @default.
• W4220681646 hasConceptScore W4220681646C197934379 @default.
• W4220681646 hasConceptScore W4220681646C42219234 @default.
• W4220681646 hasConceptScore W4220681646C44249647 @default.
• W4220681646 hasConceptScore W4220681646C61511704 @default.
• W4220681646 hasConceptScore W4220681646C71924100 @default.
• W4220681646 hasConceptScore W4220681646C90924648 @default.
• W4220681646 hasIssue "7" @default.
• W4220681646 hasLocation W42206816461 @default.
• W4220681646 hasLocation W42206816462 @default.
• W4220681646 hasLocation W42206816463 @default.
• W4220681646 hasOpenAccess W4220681646 @default.
• W4220681646 hasPrimaryLocation W42206816461 @default.
• W4220681646 hasRelatedWork W1580426574 @default.
• W4220681646 hasRelatedWork W1982619745 @default.
• W4220681646 hasRelatedWork W2089620537 @default.
• W4220681646 hasRelatedWork W2275480158 @default.

• next